200 related articles for article (PubMed ID: 2001536)
1. Stage IV neuroblastoma in infants. Long-term survival.
Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
[TBL] [Abstract][Full Text] [Related]
2. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children's Hospital experience.
Rosen EM; Cassady JR; Frantz CN; Kretschmar C; Levey R; Sallan SE
J Clin Oncol; 1984 Jul; 2(7):719-32. PubMed ID: 6737018
[TBL] [Abstract][Full Text] [Related]
4. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French society of pediatric oncology.
Minard V; Hartmann O; Peyroulet MC; Michon J; Coze C; Defachelle AS; Lejars O; Perel Y; Bergeron C; Boutard P; Leverger G; Stephan JL; Thyss A; Chastagner P; Couillault G; Devalck C; Lutz P; Mechinaud F; Millot F; Plantaz D; Rialland X; Rubie H
Br J Cancer; 2000 Oct; 83(8):973-9. PubMed ID: 10993641
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma in adults and adolescents: an indolent course with poor survival.
Franks LM; Bollen A; Seeger RC; Stram DO; Matthay KK
Cancer; 1997 May; 79(10):2028-35. PubMed ID: 9149032
[TBL] [Abstract][Full Text] [Related]
6. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
7. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Nickerson HJ; Matthay KK; Seeger RC; Brodeur GM; Shimada H; Perez C; Atkinson JB; Selch M; Gerbing RB; Stram DO; Lukens J
J Clin Oncol; 2000 Feb; 18(3):477-86. PubMed ID: 10653863
[TBL] [Abstract][Full Text] [Related]
8. Improved prognosis for infants with stage IV neuroblastoma.
Kretschmar CS; Frantz CN; Rosen EM; Cassady JR; Levey R; Sallan SE
J Clin Oncol; 1984 Jul; 2(7):799-803. PubMed ID: 6737020
[TBL] [Abstract][Full Text] [Related]
9. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
10. [MIBG scintigraphy in neuroblastoma: something more than an image].
Díez Jiménez L; Mitjavila Casanovas M
Rev Esp Med Nucl; 2006; 25(2):118-43. PubMed ID: 16759621
[No Abstract] [Full Text] [Related]
11. The role of surgery in stage IV neuroblastoma.
Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
[TBL] [Abstract][Full Text] [Related]
12. Disease outcome may be predicted by molecular detection of minimal residual disease in bone marrow in advanced neuroblastoma: a pilot study.
Fukuda M; Miyajima Y; Miyashita Y; Horibe K
J Pediatr Hematol Oncol; 2001 Jan; 23(1):10-3. PubMed ID: 11196262
[TBL] [Abstract][Full Text] [Related]
13. Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.
Stram DO; Matthay KK; O'Leary M; Reynolds CP; Haase GM; Atkinson JB; Brodeur GM; Seeger RC
J Clin Oncol; 1996 Sep; 14(9):2417-26. PubMed ID: 8823319
[TBL] [Abstract][Full Text] [Related]
14. Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma.
De Bernardi B; Pianca C; Boni L; Brisigotti M; Carli M; Bagnulo S; Corciulo P; Mancini A; De Laurentis C; Di Tullio MT
Cancer; 1992 Sep; 70(6):1625-33. PubMed ID: 1516016
[TBL] [Abstract][Full Text] [Related]
15. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
[TBL] [Abstract][Full Text] [Related]
16. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
Canete A; Gerrard M; Rubie H; Castel V; Di Cataldo A; Munzer C; Ladenstein R; Brichard B; Bermúdez JD; Couturier J; de Bernardi B; Pearson AJ; Michon J
J Clin Oncol; 2009 Mar; 27(7):1014-9. PubMed ID: 19171715
[TBL] [Abstract][Full Text] [Related]
17. Age and prognosis in neuroblastoma. Review of 112 patients younger than 2 years.
Jereb B; Bretsky SS; Vogel R; Helson L
Am J Pediatr Hematol Oncol; 1984; 6(3):233-43. PubMed ID: 6517224
[TBL] [Abstract][Full Text] [Related]
18. [Hepatopathy in patients with stage 4S neuroblastoma].
Claviez A; Hero B; Schneppenheim R; Berthold F
Klin Padiatr; 1996; 208(4):221-8. PubMed ID: 8926687
[TBL] [Abstract][Full Text] [Related]
19. Neuroblastoma: treatment outcome after incomplete resection of primary tumors.
Moon SB; Park KW; Jung SE; Youn WJ
Pediatr Surg Int; 2009 Sep; 25(9):789-93. PubMed ID: 19629500
[TBL] [Abstract][Full Text] [Related]
20. Lack of N-myc-amplification and normal karyotype in stage IV-N neuroblastoma.
Toren A; Mandel M; Passwell J; Biniaminov M; Neumann Y; Rosenthal E; Kende G; Kenet G; Brok-Simoni F; Rechavi G
Acta Oncol; 1996; 35(4):496-8. PubMed ID: 8695170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
